Personal information

No personal information available

Activities

Collapse all

Employment (1)

Leids Universitair Medisch Centrum: Leiden, Zuid-Holland, NL

2020-02-01 to present | PhD (Radiotherapy)
Employment
Source: Self-asserted source
Anne-Sophie van den Heerik

Works (5)

QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction

JCO Global Oncology
2023-05 | Journal article
DOI: 10.1200/GO.22.00384
Contributors: Anne Sophie V.M. Van den Heerik; Natalja T. Ter Haar; Lisa Vermij; Jan J. Jobsen; Mariel Brinkhuis; Suzan M. Roothaan; Alicia Leon-Castillo; Gitte Ortoft; Estrid Hogdall; Claus Hogdall et al.
Source: check_circle
Crossref

Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials

Gynecologic Oncology
2022-09 | Journal article
DOI: 10.1016/j.ygyno.2022.06.027
Part of ISSN: 0090-8258
Contributors: Anne-Sophie van den Heerik; A.S.V.M. van den Heerik; K.T.S. Aiyer; E. Stelloo; I.M. Jürgenliemk-Schulz; L.C.H.W. Lutgens; J.J. Jobsen; J.W.M. Mens; E.M. van der Steen-Banasik; C.L. Creutzberg et al.
Source: Self-asserted source
Anne-Sophie van den Heerik

Vaginal brachytherapy management of stage I and II endometrial cancer

International Journal of Gynecological Cancer
2022-03 | Journal article
DOI: 10.1136/ijgc-2021-002493
Contributors: Anne Sophie V M van den Heerik; Nanda Horeweg; Carien L Creutzberg; Remi A Nout
Source: check_circle
Crossref

Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy

International Journal of Gynecological Cancer
2021-04 | Journal article
DOI: 10.1136/ijgc-2020-001822
Contributors: Anne Sophie V M van den Heerik; Nanda Horeweg; Stephanie M de Boer; Tjalling Bosse; Carien L Creutzberg
Source: check_circle
Crossref

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

International Journal of Gynecological Cancer
2020-12 | Journal article
DOI: 10.1136/ijgc-2020-001929
Contributors: Anne Sophie V M van den Heerik; Nanda Horeweg; Remi A Nout; Ludy C H W Lutgens; Elzbieta M van der Steen-Banasik; G Henrike Westerveld; Hetty A van den Berg; Annerie Slot; Friederike L A Koppe; Stefan Kommoss et al.
Source: check_circle
Crossref
How many people are using ORCID?